{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:03:55Z","timestamp":1784048635051,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06045-x","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:10:49Z","timestamp":1784002249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating microRNAs as Promising Biomarkers in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"63","author":[{"given":"Ibrahim Alper","family":"Kaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berna","family":"Demircan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Betul","family":"Ozdilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine Sena","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saniye","family":"Koc Ada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammet Caglar","family":"Bursa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asl\u0131 Pelin","family":"Kaya Bursa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"\u00d6ztekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Hakan","family":"Gurvit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"1","key":"6045_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon DK, Tanner CM, Brundin P (2020) Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med 36(1):1\u201312. https:\/\/doi.org\/10.1016\/j.cger.2019.08.002","journal-title":"Clin Geriatr Med"},{"issue":"6","key":"6045_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5(6):525\u2013535. https:\/\/doi.org\/10.1016\/S1474-4422(06)70471-9","journal-title":"Lancet Neurol"},{"issue":"4","key":"6045_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J (2008) Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79(4):368\u2013376. https:\/\/doi.org\/10.1136\/jnnp.2007.131045","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"6045_CR4","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/00207454.2020.1784165","volume":"131","author":"B Ozdilek","year":"2020","unstructured":"Ozdilek B, Demircan B (2020) Serum microRNA expression levels in Turkish patients with Parkinson\u2019s disease. Int J Neurosci 131(12):1181\u20131189. https:\/\/doi.org\/10.1080\/00207454.2020.1784165","journal-title":"Int J Neurosci"},{"issue":"2","key":"6045_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"issue":"1","key":"6045_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12974-019-1532-2","volume":"16","author":"PJ Hallett","year":"2019","unstructured":"Hallett PJ, Engelender S, Isacson O (2019) Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson\u2019s disease. J Neuroinflammation 16(1):153. https:\/\/doi.org\/10.1186\/s12974-019-1532-2","journal-title":"J Neuroinflammation"},{"key":"6045_CR7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fnmol.2017.00352","volume":"10","author":"AR Arshad","year":"2017","unstructured":"Arshad AR, Sulaiman SA, Saperi AA, Jamal R, Mohamed Ibrahim N, Abdul Murad NA (2017) MicroRNAs and target genes as biomarkers for the diagnosis of early onset of Parkinson disease. Front Mol Neurosci 10:352. https:\/\/doi.org\/10.3389\/fnmol.2017.00352","journal-title":"Front Mol Neurosci"},{"key":"6045_CR8","doi-asserted-by":"publisher","unstructured":"Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Therapeutics 69(3):89\u201395. https:\/\/doi.org\/10.1067\/mcp.2001.113989","DOI":"10.1067\/mcp.2001.113989"},{"issue":"Pt 11","key":"6045_CR9","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/brain\/awp234","volume":"132","author":"M Selikhova","year":"2009","unstructured":"Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinico-pathological study of subtypes in Parkinson\u2019s disease. Brain\u202f: A J Neurol 132(Pt 11):2947\u20132957. https:\/\/doi.org\/10.1093\/brain\/awp234","journal-title":"Brain : A J Neurol"},{"key":"6045_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.dscb.2025.100297","volume":"20","author":"N Aghakhani","year":"2025","unstructured":"Aghakhani N, Arzoo A, Dorflinger B, Athari SZ, Mohaddes G (2025) Early diagnosis of Parkinson\u2019s disease pathogenesis using biofluidic biomarkers with a focus on \u03b1-synuclein. Brain Disord 20:100297. https:\/\/doi.org\/10.1016\/j.dscb.2025.100297","journal-title":"Brain Disord"},{"issue":"7","key":"6045_CR11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/s0092-8674(01)00616-x","volume":"107","author":"V Ambros","year":"2001","unstructured":"Ambros V (2001) MicroRNAs: tiny regulators with great potential. Cell 107(7):823\u2013826. https:\/\/doi.org\/10.1016\/s0092-8674(01)00616-x","journal-title":"Cell"},{"key":"6045_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev.neuro.29.051605.112839","volume":"29","author":"X Cao","year":"2006","unstructured":"Cao X, Yeo G, Muotri AR, Kuwabara T, Gage FH (2006) Noncoding RNAs in the mammalian central nervous system. Annu Rev Neurosci 29:77\u2013103. https:\/\/doi.org\/10.1146\/annurev.neuro.29.051605.112839","journal-title":"Annu Rev Neurosci"},{"key":"6045_CR13","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstr\u00f6m K, Bossios A et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654\u2013659. https:\/\/doi.org\/10.1038\/ncb1596","journal-title":"Nat Cell Biol"},{"issue":"12","key":"6045_CR14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nrn2726","volume":"10","author":"SM Eacker","year":"2009","unstructured":"Eacker SM, Dawson TM, Dawson VL (2009) Understanding microRNAs in neurodegeneration. Nat Rev Neurosci 10(12):837\u2013841. https:\/\/doi.org\/10.1038\/nrn2726","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"6045_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2045-8118-10-4","volume":"10","author":"AS Haqqani","year":"2013","unstructured":"Haqqani AS, Delaney CE, Tremblay TL, Sodja C, Sandhu JK, Stanimirovic DB (2013) Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells. Fluids Barriers CNS 10(1):4. https:\/\/doi.org\/10.1186\/2045-8118-10-4","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"6045_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55(4):611\u2013622. https:\/\/doi.org\/10.1373\/clinchem.2008.112797","journal-title":"Clin Chem"},{"issue":"6","key":"6045_CR17","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/clinchem\/hvaf043","volume":"71","author":"SA Bustin","year":"2025","unstructured":"Bustin SA, Ruijter JM, van den Hoff MJB, Kubista M, Pfaffl MW, Shipley GL, Tran N, R\u00f6diger S, et al. (2025) MIQE 2.0: revision of the minimum information for publication of quantitative real-time PCR experiments guidelines. Clin Chem 71(6):634\u2013651. https:\/\/doi.org\/10.1093\/clinchem\/hvaf043","journal-title":"Clin Chem"},{"key":"6045_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43096-9","volume":"13","author":"D Gu\u00e9vremont","year":"2023","unstructured":"Gu\u00e9vremont D, Roy J, Cutfield NJ et al (2023) MicroRNAs in Parkinson\u2019s disease: a systematic review and diagnostic accuracy meta-analysis. Sci Rep 13:16272. https:\/\/doi.org\/10.1038\/s41598-023-43096-9","journal-title":"Sci Rep"},{"key":"6045_CR19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41531-024-00791-2","volume":"10","author":"N Shaheen","year":"2024","unstructured":"Shaheen N, Shaheen A, Osama M et al (2024) MicroRNAs regulation in Parkinson\u2019s disease, and their potential role as diagnostic and therapeutic targets. npj Parkinsons Dis 10:186. https:\/\/doi.org\/10.1038\/s41531-024-00791-2","journal-title":"npj Parkinsons Dis"},{"issue":"6","key":"6045_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064795","volume":"8","author":"HH Cheng","year":"2013","unstructured":"Cheng HH, Yi HS, Kim Y, Kroh EM, Chien JW, Eaton KD, Goodman MT, Tait JF, et al. (2013) Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS ONE 8(6):e64795. https:\/\/doi.org\/10.1371\/journal.pone.0064795","journal-title":"PLoS ONE"},{"issue":"6","key":"6045_CR21","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3(6):1101\u20131108. https:\/\/doi.org\/10.1038\/nprot.2008.73","journal-title":"Nat Protoc"},{"key":"6045_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fnagi.2017.00232","volume":"9","author":"Y Chen","year":"2017","unstructured":"Chen Y, Gao C, Sun Q, Pan H, Huang P, Ding J, Chen S (2017) MicroRNA-4639 is a regulator of DJ-1 expression and a potential early diagnostic marker for Parkinson\u2019s disease. Front Aging Neurosci 9:232. https:\/\/doi.org\/10.3389\/fnagi.2017.00232","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"6045_CR23","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1373\/clinchem.2015.239459","volume":"61","author":"H Schwarzenbach","year":"2015","unstructured":"Schwarzenbach H, da Silva AM, Calin G, Pantel K (2015) Data normalization strategies for microRNA quantification. Clin Chem 61(11):1333\u20131342. https:\/\/doi.org\/10.1373\/clinchem.2015.239459","journal-title":"Clin Chem"},{"issue":"1","key":"6045_CR24","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41597-024-03909-6","volume":"11","author":"L Zhiyang","year":"2024","unstructured":"Zhiyang L, Koseki S, Seki M et al (2024) Serum exosome microRNA transcriptome dataset of Parkinson\u2019s disease patients and healthy subjects. Scientific Data 11(1):1079. https:\/\/doi.org\/10.1038\/s41597-024-03909-6. ([Dataset:GSE269775])","journal-title":"Scientific Data"},{"issue":"D1","key":"6045_CR25","doi-asserted-by":"publisher","first-page":"D239","DOI":"10.1093\/nar\/gkx1141","volume":"46","author":"D Karagkouni","year":"2018","unstructured":"Karagkouni D, Paraskevopoulou MD, Chatzopoulos S et al (2018) DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions. Nucleic Acids Res 46(D1):D239\u2013D245. https:\/\/doi.org\/10.1093\/nar\/gkx1141","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6045_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cell.2010.03.009","volume":"141","author":"M Hafner","year":"2010","unstructured":"Hafner M, Landthaler M, Burger L et al (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141(1):129\u2013141. https:\/\/doi.org\/10.1016\/j.cell.2010.03.009","journal-title":"Cell"},{"issue":"3","key":"6045_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nbt.2839","volume":"32","author":"JA Vizcaino","year":"2014","unstructured":"Vizcaino JA, Deutsch EW, Wang R et al (2014) ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol 32(3):223\u2013226. https:\/\/doi.org\/10.1038\/nbt.2839. ([Dataset:PXD011216,CSFDIAproteomics;74PD,115HC])","journal-title":"Nat Biotechnol"},{"issue":"17","key":"6045_CR28","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gku631","volume":"42","author":"Y Ru","year":"2014","unstructured":"Ru Y, Kechris KJ, Tabakoff B et al (2014) The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations. Nucleic Acids Res 42(17):e133. https:\/\/doi.org\/10.1093\/nar\/gku631","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"6045_CR29","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D et al (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"key":"6045_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-01126-5","author":"J Gervasoni","year":"2025","unstructured":"Gervasoni J, Marino C, Imarisio A et al (2025) Independent serum metabolomics approaches identify disrupted glutamic acid and serine metabolism in Parkinson\u2019s disease patients. npj Parkinsons Dis. https:\/\/doi.org\/10.1038\/s41531-025-01126-5. ([Dataset: MTBLS10958])"},{"key":"6045_CR31","unstructured":"Oliveira SR, Santana I, Baldeiras I et al (2011) Differential Peripheral Lymphocyte Expression Levels of \u03b1-Synuclein and Tau Following Rivastigmine Treatment. J Alzheimers Dis 27(3):527-535. [GSE16658, PBMC miRNA array, Exiqon miRCURY v10]"},{"issue":"2","key":"6045_CR32","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3390\/ijms26020626","volume":"26","author":"RK Yashooa","year":"2025","unstructured":"Yashooa RK, Duranti E, Conconi D, Lavitrano M, Mustafa SA, Villa C (2025) Mitochondrial microRNAs: key drivers in unraveling neurodegenerative diseases. Int J Mol Sci 26(2):626. https:\/\/doi.org\/10.3390\/ijms26020626","journal-title":"Int J Mol Sci"},{"key":"6045_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2013.00040","volume":"6","author":"SM Heman-Ackah","year":"2013","unstructured":"Heman-Ackah SM, Hallegger M, Rao MS, Wood MJ (2013) RISC in PD: the impact of microRNAs in Parkinson\u2019s disease cellular and molecular pathogenesis. Front Mol Neurosci 6:40. https:\/\/doi.org\/10.3389\/fnmol.2013.00040","journal-title":"Front Mol Neurosci"},{"key":"6045_CR34","doi-asserted-by":"publisher","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonz\u00e1lez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, \u2026 Wood NW (2004) Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science (New York, N.Y.) 304(5674):1158\u20131160. https:\/\/doi.org\/10.1126\/science.1096284","DOI":"10.1126\/science.1096284"},{"key":"6045_CR35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10571-019-00751-y","volume":"40","author":"C Barbagallo","year":"2020","unstructured":"Barbagallo C, Mostile G, Baglieri G et al (2020) Specific signatures of serum miRNAs as potential biomarkers to discriminate clinically similar neurodegenerative and vascular-related diseases. Cell Mol Neurobiol 40:531\u2013546. https:\/\/doi.org\/10.1007\/s10571-019-00751-y","journal-title":"Cell Mol Neurobiol"},{"key":"6045_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00156","volume":"8","author":"A Vallelunga","year":"2014","unstructured":"Vallelunga A, Ragusa M, Di Mauro S, Iannitti T, Pilleri M, Biundo R, Weis L, Di Pietro C, et al. (2014) Identification of circulating microRNAs for the differential diagnosis of Parkinson\u2019s disease and Multiple System Atrophy. Front Cell Neurosci 8:156. https:\/\/doi.org\/10.3389\/fncel.2014.00156","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"6045_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13041-019-0471-2","volume":"12","author":"H Uwatoko","year":"2019","unstructured":"Uwatoko H, Hama Y, Iwata IT, Shirai S, Matsushima M, Yabe I, Utsumi J, Sasaki H (2019) Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson\u2019s disease. Mol Brain 12(1):49. https:\/\/doi.org\/10.1186\/s13041-019-0471-2","journal-title":"Mol Brain"},{"issue":"10","key":"6045_CR38","doi-asserted-by":"publisher","first-page":"7736","DOI":"10.1007\/s12035-016-0253-0","volume":"54","author":"TM Marques","year":"2017","unstructured":"Marques TM, Kuiperij HB, Bruinsma IB, van Rumund A, Aerts MB, Esselink RAJ, Bloem BR, Verbeek MM (2017) MicroRNAs in cerebrospinal fluid as potential biomarkers for Parkinson\u2019s disease and Multiple System Atrophy. Mol Neurobiol 54(10):7736\u20137745. https:\/\/doi.org\/10.1007\/s12035-016-0253-0","journal-title":"Mol Neurobiol"},{"issue":"5","key":"6045_CR39","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1007\/s00415-013-6900-8","volume":"260","author":"LF Cardo","year":"2013","unstructured":"Cardo LF, Coto E, de Mena L, Ribacoba R, Moris G, Men\u00e9ndez M, Alvarez V (2013) Profile of microRNAs in the plasma of Parkinson\u2019s disease patients and healthy controls. J Neurol 260(5):1420\u20131422. https:\/\/doi.org\/10.1007\/s00415-013-6900-8","journal-title":"J Neurol"},{"issue":"16","key":"6045_CR40","doi-asserted-by":"publisher","first-page":"5278","DOI":"10.26355\/eurrev_201808_15727","volume":"22","author":"YF Yao","year":"2018","unstructured":"Yao YF, Qu MW, Li GC, Zhang FB, Rui HC (2018) Circulating exosomal miRNAs as diagnostic biomarkers in Parkinson\u2019s disease. Eur Rev Med Pharmacol Sci 22(16):5278\u20135283. https:\/\/doi.org\/10.26355\/eurrev_201808_15727","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06045-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06045-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06045-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:03:37Z","timestamp":1784045017000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06045-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6045"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06045-x","relation":{"references":[{"id-type":"doi","id":"10.1038\/s41531-025-01126-5","asserted-by":"subject"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors affirm that human research participants provided informed consent for participation and publication, both in written and verbally, along with the ethics committee approval under the decision number 2017\/0201 dated June 6, 2017.","order":1,"name":"Ethics","label":"Consent to Participate and Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"758"}}